Vistagen Therapeutics's top three insider shareholders as of March 23, 2026 are Healthcare Capital Partners Ii, L.P. Venrock (TenPercentOwner, 20.64Mn shares), Capital Lp Commodore (TenPercentOwner, 1.57Mn shares), Shawn Singh (Chief Executive Officer, 626.23K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Healthcare Capital Partners Ii, L.P. Venrock | 0 | 20,637,286 | 14 Jul, 2022 | |
| Capital Lp Commodore | 0 | 1,575,000 | 09 Aug, 2023 | |
| Shawn Singh | Chief Executive Officer | 0 | 626,234 | 18 Aug, 2022 |
| H. Ralph Snodgrass | Pres./Chief Scientific Officer | 64,958 | 0 | 03 Jan, 2022 |
| H. Ralph Snodgrass | Pres./Chief Scientific Officer | 0 | 33,901 | 03 Sep, 2021 |
| Reid G. Adler | Chief Legal Officer | 24,050 | 0 | 01 Jul, 2025 |
| Mark Alan Smith | Chief Medical Officer | 19,915 | 0 | 15 Jul, 2022 |
| Shawn Singh | President And Ceo | 18,028 | 0 | 01 Jul, 2025 |
| Joshua S. Prince | Chief Operating Officer | 15,249 | 0 | 05 Jan, 2026 |
| Cynthia Lynn Anderson | Chief Financial Officer | 12,801 | 0 | 01 Jul, 2025 |
| Jerrold Duane Dotson | Vp, Cfo | 3,671 | 0 | 05 Jul, 2023 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 31 Dec, 2025 | Joshua S. Prince | Common Stock | A | 4,386 | $0.56 | 15,249 | D | A |
| 01 Dec, 2025 | Nick B. Tressler | Common Stock (Right to Buy) | A | 150,000 | - | 150,000 | D | A |
| 27 Oct, 2025 | Paul R Edick | Stock Option (Right to Buy) | A | 35,200 | - | 35,200 | D | A |
| 09 Sep, 2025 | Margaret M Fitzpatrick | Non-Qualified Stock Option (right to buy) | A | 17,600 | $0.00 | 17,600 | D | A |
| 09 Sep, 2025 | Ann Michelle Cunningham | Non-Qualified Stock Option (right to buy) | A | 17,600 | $0.00 | 17,600 | D | A |
| 09 Sep, 2025 | Joanne Curley | Non-Qualified Stock Option (right to buy) | A | 17,600 | $0.00 | 17,600 | D | A |
| 09 Sep, 2025 | Mary L. Rotunno | Non-Qualified Stock Option (right to buy) | A | 17,600 | $0.00 | 17,600 | D | A |
| 30 Jun, 2025 | Joshua S. Prince | Common Stock | A | 4,882 | $1.70 | 10,863 | D | A |
| 30 Jun, 2025 | Shawn Singh | Common Stock | A | 7,541 | $1.70 | 18,028 | D | A |
| 30 Jun, 2025 | Reid G. Adler | Common Stock | A | 7,541 | $1.70 | 24,050 | D | A |
| 30 Jun, 2025 | Cynthia Lynn Anderson | Common Stock | A | 6,617 | $1.70 | 12,801 | D | A |
| 23 Jun, 2025 | Elissa S. Cote | Stock Option (Right to Buy) | A | 150,000 | $0.00 | 150,000 | D | A |
| 23 Jun, 2025 | Shawn Singh | Stock Option (Right to Buy) | A | 300,000 | $0.00 | 300,000 | D | A |
| 23 Jun, 2025 | Joshua S. Prince | Stock Option (Right to Buy) | A | 100,000 | $0.00 | 100,000 | D | A |
| 23 Jun, 2025 | Reid G. Adler | Stock Option (Right to Buy) | A | 100,000 | $0.00 | 100,000 | D | A |
| 23 Jun, 2025 | Cynthia Lynn Anderson | Stock Option (Right to Buy) | A | 100,000 | $0.00 | 100,000 | D | A |
| 31 Dec, 2024 | Cynthia Lynn Anderson | Common Stock | A | 2,592 | $2.51 | 6,184 | D | A |
| 31 Dec, 2024 | Joshua S. Prince | Common Stock | A | 3,310 | $2.51 | 5,981 | D | A |
| 06 Sep, 2024 | Mary L. Rotunno | Stock Option (Right to Buy) | A | 14,100 | $0.00 | 14,100 | D | A |
| 06 Sep, 2024 | Ann Michelle Cunningham | Stock Option (Right to Buy) | A | 14,100 | $0.00 | 14,100 | D | A |